A dissolvable drug capsule uses radiofrequency signals to ensure that people are taking their medication on schedule ...
Statements about, among other things, the Company’s business, the Company’s ability to advance clinical research activities, realize on its objectives and obtain regulatory approval of ...
The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results